(Q27851611)

13 November 2016

title

A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma (English)

1 reference

13 November 2016

1 reference

S E Godshalk

1

0 references

T Paranjape

2

0 references

S Nallur

3

0 references

W Speed

4

0 references

E Chan

5

0 references

A M Molinaro

6

0 references

A Bacchiocchi

7

0 references

K Hoyt

8

0 references

K Tworkoski

9

0 references

D F Stern

10

0 references

M Sznol

11

0 references

S Ariyan

12

0 references

R Lazova

13

0 references

R Halaban

14

0 references

K K Kidd

15

0 references

J B Weidhaas

16

0 references

F J Slack

A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk

17

0 references

language of work or name

English

0 references

publication date

31 March 2011

0 references

published in

Oncogene

0 references

volume

30

0 references

issue

13

0 references

page(s)

1542-50

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Major response to imatinib mesylate in KIT-mutated melanoma.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

The role of microRNA genes in papillary thyroid carcinoma

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

dbSNP: the NCBI database of genetic variation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications

20 March 2017

1 reference

https://api.crossref.org/works/10.1038/ONC.2010.536

Database resources of the National Center for Biotechnology Information

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Genetic risk factors for melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Genetic subgrouping of melanoma reveals new opportunities for targeted therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

ALFRED: an allele frequency database for microevolutionary studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

c-KIT signaling as the driving oncogenic event in sub-groups of melanomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

MicroRNA-dependent regulation of cKit in cutaneous melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Imatinib targeting of KIT-mutant oncoprotein in melanoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

microRNAs and cancer: an overview

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Roles of microRNAs and their targets in cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Evolutionary conservation of microRNA regulatory circuits: an examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Somatic activation of KIT in distinct subtypes of melanoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

c-Kit-kinase induces a cascade of protein tyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Progression of human cutaneous melanoma is associated with loss of expression of c-kit proto-oncogene receptor.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Epstein-Barr virus-mediated dysregulation of human microRNA expression

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Prevalence of KIT expression in human tumors

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3069149

2010 TNM staging system for cutaneous melanoma...and beyond

27 November 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.536

Genome-wide screen of promoter methylation identifies novel markers in melanoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.536

c-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.536

Trends in dermatology: melanoma incidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.536

Global variation in CYP2C8-CYP2C9 functional haplotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.536

Loss of c-kit expression in cultured melanoma cells

31 March 2020

1 reference

https://pubmed.ncbi.nlm.nih.gov/21119596

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21119596

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/ONC.2010.536

0 references

Dimensions Publication ID

0 references

1 reference

13 November 2016

1 reference